Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.1982
-0.0015 (-0.75%)
At close: Apr 24, 2026, 4:00 PM EDT
0.1975
-0.0007 (-0.35%)
After-hours: Apr 24, 2026, 7:30 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $8.89 million as of April 24, 2026. Its market cap has decreased by -89.06% in one year.
Market Cap
8.89M
Enterprise Value
10.00M
1-Year Change
-89.06%
Ranking
Category
Stock Price
$0.20
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $8.89M, a decrease of -97.43%. That is a compound annual growth rate of -52.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 8.89M | -46.12% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | 346.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 11.37M |
| Aprea Therapeutics | 10.88M |
| Kiora Pharmaceuticals | 10.71M |
| Bolt Biotherapeutics | 10.36M |
| Quoin Pharmaceuticals | 10.35M |
| Evogene | 9.77M |
| BioAtla | 9.68M |
| CalciMedica | 9.54M |